Baystate Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $35.1K | Buy |
364
+64
| +21% | +$6.17K | ﹤0.01% | 442 |
|
|
2023
Q3 | $26.5K | Hold |
300
| – | – | ﹤0.01% | 437 |
|
|
2023
Q2 | $26K | Sell |
300
-100
| -25% | -$8.67K | ﹤0.01% | 426 |
|
|
2023
Q1 | $38.9K | Hold |
400
| – | – | ﹤0.01% | 365 |
|
|
2022
Q4 | $41K | Buy |
+400
| New | +$41K | ﹤0.01% | 356 |
|
|
2017
Q3 | – | Sell |
-10
| Closed | -$1K | – | 654 |
|
|
2017
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 553 |
|
|
2017
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 516 |
|